Acta Scientific Cancer Biology (ASCB)

EditorialVolume 9 Issue 3

POSTCOVID-19 WAR Era, Cancer Diagnostics Problems, Dual Risk Profiling Yes or No?

Bahram Alamdary Badlou*

Hematology Platelets; MSc Medical Biology Cardiology with NMR, BBAdvies and Research, Research and Development, Utrecht, The Netherlands

*Corresponding Author: Bahram Alamdary Badlou, Hematology Platelets; MSc Medical Biology Cardiology with NMR, BBAdvies and Research, Research and Development, Utrecht, The Netherlands.

Received: August 30, 2025; Published: August 31, 2025

×

Cancer and cancerogenic processes are the second cause of increased morbidity and mortality rates pre- and POSTCOVID-19 pandemic attacks periods, although in some countries Alzheimer/Dementia mortality rates (!) have increased, however, worldwide. On the other hand, cancer mortality statistics for 2025 are not yet fully compiled, but global trends show a growing burden, with lung and breast cancer being major causes of death globally. The World Health Organization (WHO) indicates that in 2024, 685,000 deaths were attributed to breast cancer and 1.80 million to lung cancer.

×

Citation

Citation: Bahram Alamdary Badlou. “POSTCOVID-19 WAR Era, Cancer Diagnostics Problems, Dual Risk Profiling Yes or No?".Acta Scientific Cancer Biology 9.3 (2025): 01-03.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Reviewer Certificate
    Certificate will be issues to the valued reviewer who worked on the Articles Peer Review process.
  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit their manuscripts before September 30, 2025

Contact US